Retatrutide
Research Overview

Retatrutide is the investigational single-peptide agonist LY3437943 with activity at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors.

Research context

Retatrutide has published phase 2 clinical data and remains investigational while phase 3 trials continue. The glucagon receptor is conventionally abbreviated GCGR. Current evidence does not establish guaranteed beta-cell protection or an approved therapeutic use.

Common analytical research areas
  • GIPR, GLP-1R, and GCGR binding and functional selectivity.
  • Triple-agonist structure-activity and signaling bias.
  • Peptide identity, purity, and stability analysis.
Selected scientific references

Research-use notice: Supplied exclusively for laboratory research and analytical use. Not for human or veterinary use, diagnosis, treatment, food, cosmetic, or household use.

Specification record updated 26 Sept 2026. External database links are provided for research context; verify primary sources before analytical use.

Uncategorized

Retatrutide

Overview

Triple GLP-1 / GIP / Glucagon agonist — the most powerful research peptide for fat loss.

Rs. 3,999.00
Request Certificate of Analysis
Get the third-party COA for this product via WhatsApp
❯
Product Specifications
Product class Triple-receptor agonist peptide
Research name Retatrutide / LY3437943
Available sizes 10 mg, 20 mg, 30 mg
Regulatory status Investigational; not an approved medicine
Purity >99% by HPLC
Intended use Laboratory research only
Research Overview

Retatrutide is the investigational single-peptide agonist LY3437943 with activity at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors.

Research context

Retatrutide has published phase 2 clinical data and remains investigational while phase 3 trials continue. The glucagon receptor is conventionally abbreviated GCGR. Current evidence does not establish guaranteed beta-cell protection or an approved therapeutic use.

Common analytical research areas
  • GIPR, GLP-1R, and GCGR binding and functional selectivity.
  • Triple-agonist structure-activity and signaling bias.
  • Peptide identity, purity, and stability analysis.
Selected scientific references

Research-use notice: Supplied exclusively for laboratory research and analytical use. Not for human or veterinary use, diagnosis, treatment, food, cosmetic, or household use.

Specification record updated 26 Sept 2026. External database links are provided for research context; verify primary sources before analytical use.

Uses

Fat loss

Appetite control

Muscle retention

Research use Laboratory supply only
Batch verified COA per batch, always
India dispatch Secure checkout and tracking

You may also like